Navigation Links
CardioMEMS CFO, Dan Bauer, Wins the Delaney Consulting 2011 Excellence in Finance and Accounting Award
Date:11/28/2011

ATLANTA, Nov. 28, 2011 /PRNewswire/ -- CardioMEMS, Inc., an Atlanta-based medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, today announced that Chief Financial Officer, Dan Bauer, has won Delaney Consulting, LLC's 2011 Excellence in Financing and Accounting Award in the fast-growth category. The Delaney awards acknowledge accounting and finance professionals from the Metro Atlanta area who exemplify ethics and excellence in their profession and demonstrate exceptional skill, teamwork, and the advancement and application of technical accounting and financial knowledge.

The award ceremony was held at the City Club of Buckhead on November 16, 2011. Five awards were presented, representing emerging growth, fast growth (under $500 million) and large (over $500 million) businesses. A diversity award and a CFOradio Listener's Choice award were also presented. A panel of professionals representing the finance, accounting, and education fields judged the awards.                  

Mr. Bauer began his career at Price Waterhouse and previously served as the Chief Financial Officer for Industriaplex, Granite City Food and Brewery, and Church's Chicken, the largest division of AFC Enterprises.  He is currently a board member for the Association for Corporate Growth, a member of the advisory board of Emerge Scholarships, and an alumnus of Leadership Atlanta.

More information on the Delaney Consulting, LLC Excellence in Financing and Accounting Awards can be found at http://www.delaneyawards.com.

About Delaney Consulting, LLC

Delaney Consulting, LLC is a financial services and executive search firm that provides financial expertise to help companies achieve their financial goals. Clients engage Delaney CFOs and Controllers for their specialized financial experience and skill, whether needed on an interim, part-time or per-project basis. Clients also use Delaney's retained placement services to fit the unique needs of companies during any stage of their business lifecycle – whether the company is growing, optimizing stability or undergoing challenges.

About CardioMEMS, Inc.

CardioMEMS is a medical device company that has developed and is commercializing proprietary wireless sensing and communication technology for the human body. The company's technology platform is designed to improve the management of severe chronic cardiovascular diseases such as aneurysms, heart failure, and hypertension. CardioMEMS miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data, which are critical to the management of patients. The sensors are designed to be permanently implanted into the heart and blood vessels due to their small size, durability and lack of wires and batteries. Using radiofrequency (RF) energy, the sensors transmit real-time data to external electronic readers, which then communicate this information to the patient's physician. CardioMEMS developed this technology based on the belief that frequent, on-demand, real-time monitoring of vital information enables proactive patient management, which holds the promise of reducing hospitalizations, improving a patient's quality of life and delivering more efficient and cost effective health care. More information about CardioMEMS is located at www.cardiomems.com.

Statements made in this press release that look forward in time or that express beliefs, expectations or hopes regarding future occurrences or anticipated outcomes are forward-looking statements. A number of risks and uncertainties such as risks associated with product development and commercialization efforts, expected timing or results of any clinical trials, ultimate clinical outcome and perceived or actual advantages of the Company's products, market and physician acceptance of the products, intellectual property protection, and competitive offerings could cause actual events to adversely differ from the expectations indicated in these forward looking statements.

CardioMEMS and the CardioMEMS logo are registered trademarks of CardioMEMS, Inc.


'/>"/>
SOURCE CardioMEMS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The Association of Telecom Professionals Selects Dr. Jay Yadav, CardioMEMS Founder & CEO, as an Atlanta Telecom Professional of the Year in the Industry Innovation Category
2. Dr. Jay Yadav, CardioMEMS Founder & CEO, Named Ernst & Young Entrepreneur of the Year®
3. Dr. Jay Yadav, CardioMEMS Founder & CEO, Selected as a Finalist for 2011 Business Person of the Year Award
4. CardioMEMS Founder Dr. Jay Yadav Honored With Health-Care Heroes Award by the Atlanta Business Chronicle
5. CardioMEMS Founder & CEO Dr. Jay Yadav Named Ernst & Young Entrepreneur of the Year Finalist
6. CardioMEMS Founder Dr. Jay Yadav Chosen as Health-Care Heroes Finalist by Atlanta Business Chronicle
7. CardioMEMS, Inc. Tops Georgias 2010 Venture Financing List
8. CardioMEMS, Inc. Named a TAG Top 10 Innovative Technology Company
9. CardioMEMS Recognized by Georgia Bio for Pivotal Strategic Partnership
10. Boston Millennia Partners Portfolio Company CardioMEMS Signs Equity Investment and Exclusive Option to be Acquired for an Additional $375,000,000
11. CardioMEMS Completes CHAMPION Clinical Trial Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)...   Acsis , a leading provider of supply ... research and advisory firm IDC has named it a ... Pharmaceutical Track and Trace Software 2016 Vendor Assessment (doc ... of the capabilities and business strategies of 10 vendors ... Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/28/2016)... 2016 New market research ... a report that provides an overview of the ... by identifying new targets and MOAs to produce ... discussed in this H1 2016 Osteoarthritis Pipeline report ... Inc., Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, ...
(Date:4/27/2016)... 2016   ... sur le trimestre, soutenu par une croissance de ... Croissance de +16% des ventes aux hôpitaux et ... Technologies (Euronext : MKEA, FR0010609263 ; OTCQX : MKEAY), inventeur de ... son chiffre d,affaires pour le premier trimestre clos ...
Breaking Medicine Technology:
(Date:5/2/2016)... ... May 02, 2016 , ... ... announced a new Specialty Pharmacy Patient Satisfaction Award that will recognize specialty pharmacies ... quarterly results from Zitter Health Insights’ Specialty Pharmacy Patient Satisfaction Survey compiled throughout ...
(Date:5/2/2016)... ... May 02, 2016 , ... Visceral fat, also known as ... kidneys, liver and pancreas. If not properly addressed, visceral fat can lead to ... Medicine, Medical Oncology and Palliative Care, warns against the dangers of visceral fat. ...
(Date:5/2/2016)... (PRWEB) , ... May 02, ... ... researchers report that many commonly used prescription medications, including anxiolytics, painkillers, antidepressants ... mitigate these risks, Novus Medical Detox Center —a leading Florida-based drug ...
(Date:5/2/2016)... , ... May 02, 2016 , ... Pregnancy Awareness Month ... trying to conceive. , “If you are ready to have a baby, ... “My book, HealthChequesTM: Journal Babies is your Personal Conception & Pregnancy Organizer, written ...
(Date:5/2/2016)... , ... May 02, 2016 , ... ... and urgent care facilities designed to automate and improve the rapid diagnosis, triage ... it is demonstrating their platform, application, and mobile experience for the first time ...
Breaking Medicine News(10 mins):